Business Practice

Are there learnings from the COVID-19 pandemic that could be applied to the development and commercialization of advanced therapies?

How can advocacy groups help improve the clinical trials landscape?

Does pharma have the right mindset when it comes to adopting and implementing AI more widely?

What was described by a University of California professor as gene therapy's "single most remarkable achievement?"

Is waiving patents for COVID-19 vaccines the right step forward?

Implementing sustainable practices for a better future.

A report suggests that more needs to be done to combat bleeding disorders. Is pharma playing its part in addressing this issue?

How do we vaccinate billions of people? “Nobody wins the race until everyone wins.”

What factors influence the public’s perception of the pharmaceutical industry?

COVID-19 has put the spotlight on the weaknesses of today’s highly dispersed, globalized pharma industry. Is onshoring the answer?